Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Very Severe Chronic Obstructive Pulmonary Disease”

39 trials

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT02138916
What this trial is testing

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Who this might be right for
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca 1,656
Large-scale testing (Phase 3)Study completedNCT02347072
What this trial is testing

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

Who this might be right for
COPD
Pearl Therapeutics, Inc. 80
Large-scale testing (Phase 3)Study completedNCT02268396
What this trial is testing

Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD

Who this might be right for
COPD
Pearl Therapeutics, Inc. 138
Large-scale testing (Phase 3)Study completedNCT02766608
What this trial is testing

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disorder
Pearl Therapeutics, Inc. 2,389
Large-scale testing (Phase 3)Study completedNCT02343458
What this trial is testing

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 1,756
Not applicableStudy completedNCT02128529
What this trial is testing

Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseChronic Bronchitis
AstraZeneca 976
Testing effectiveness (Phase 2)WithdrawnNCT01043601
What this trial is testing

Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Who this might be right for
COPD
Pearl Therapeutics, Inc.
Post-approval studies (Phase 4)UnknownNCT02924870
What this trial is testing

Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Hospital Universitario La Paz 128
Not applicableStudy completedNCT01529489
What this trial is testing

Effect of Two Physical Training Programs on Oxygen Uptake and Heart Rate On-kinetics in Patients COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHealthy
Universidade Federal de Sao Carlos 40
Large-scale testing (Phase 3)Study completedNCT01782326
What this trial is testing

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 3,362
Large-scale testing (Phase 3)Study completedNCT01970878
What this trial is testing

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pearl Therapeutics, Inc. 892
Large-scale testing (Phase 3)Study completedNCT02155660
What this trial is testing

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Who this might be right for
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca 2,255
Testing effectiveness (Phase 2)Study completedNCT01085045
What this trial is testing

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 118
Large-scale testing (Phase 3)Study completedNCT02727660
What this trial is testing

Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)

Who this might be right for
Chronic Obstructive Pulmonary Disorder
Pearl Therapeutics, Inc. 1,876
Large-scale testing (Phase 3)Study completedNCT02257385
What this trial is testing

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 967
Large-scale testing (Phase 3)Study completedNCT02497001
What this trial is testing

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)

Who this might be right for
COPD
Pearl Therapeutics, Inc. 1,902
Large-scale testing (Phase 3)Looking for participantsNCT06878261
What this trial is testing

Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 990
Not applicableStudy completedNCT04168775
What this trial is testing

Peak Inspiratory Flow Rates in Patients With COPD

Who this might be right for
COPD
University of North Carolina, Chapel Hill 80
Large-scale testing (Phase 3)Study completedNCT02536508
What this trial is testing

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Pearl Therapeutics, Inc. 627
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation